Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 2849 | Apatinib | Inhibitor of VEGFR2 | €125.00 | |
| 1850 | BMS 540215 | Inhibitor of VEGFR (subtype 2 and 3 selective) | €110.00 | |
| 2837 | BMS 605541 | Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor | €90.00 | |
| 1864 | Brivanib alaninate | Prodrug of BMS 540215; Inhibitor of VEGF | €105.00 | |
| 1461 | Cediranib | VEGFR tyrosine kinase inhibitor | €70.00 | |
| 1662 | CP 547632 | VEGFR2 tyrosine kinase inhibitor | €80.00 | |
| 3165 | Lenvatinib | Multi-targeted receptor tyrosine kinase inhibitor | Recently added | €70.00 |
| 1963 | LY 573636 | Anti-tumor agent; causes growth arrest and apoptosis | €80.00 | |
| 2865 | NVP-ACC789 | Inhibitor of VEGFR2 | €95.00 | |
| 1717 | Tivozanib | VEGFR1, 2, and 3 tyrosine kinase inhibitor | €99.00 | |
| 1637 | Vatalanib | VEGFR tyrosine kinase inhibitor | €75.00 | |
| 1978 | ZM 323881 hydrochloride | Inhibitor of VEGFR2 | €105.00 | |